Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
72.98
+0.18 (0.25%)
Apr 28, 2025, 9:37 AM EDT - Market open
Globus Medical Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
$96.91
Upside
+32.79%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $82 → $80 | Hold | Maintains | $82 → $80 | +9.62% | Apr 11, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $90 → $82 | Hold | Maintains | $90 → $82 | +12.36% | Mar 18, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 18, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 24, 2025 |
| Barclays | Barclays | Buy Maintains $100 → $103 | Buy | Maintains | $100 → $103 | +41.13% | Feb 24, 2025 |
| Stifel | Stifel | Strong Buy Maintains $92 → $94 | Strong Buy | Maintains | $92 → $94 | +28.80% | Feb 21, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $95 → $93 | Buy | Maintains | $95 → $93 | +27.43% | Feb 21, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 21, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 6, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $92 → $101 | Strong Buy | Maintains | $92 → $101 | +38.39% | Jan 10, 2025 |
| B of A Securities | B of A Securities | Sell → Hold Upgrades $80 → $97 | Sell → Hold | Upgrades | $80 → $97 | +32.91% | Jan 9, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 9, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $85 → $90 | Hold | Maintains | $85 → $90 | +23.32% | Dec 18, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $100 → $115 | Strong Buy | Maintains | $100 → $115 | +57.58% | Dec 17, 2024 |
| BTIG | BTIG | Strong Buy Maintains $87 → $91 | Strong Buy | Maintains | $87 → $91 | +24.69% | Dec 12, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $88 → $95 | Buy | Maintains | $88 → $95 | +30.17% | Dec 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.